ABSTRACT Among bone-marrow-derived (B) lymphocytes exist subpopulations of cells that can be induced to express the markers: surface immunoglobulin (Ig), the antigen associated with the immune response gene (Ia), and the receptor for the third complement component (CR). Inducible cells for the first two markers are found in bone marrow, and inducible cells for all three are in spleen. Experiments were designed to determine whether induction involves a single precursor cell population that on triggering with lipopolysaccharide expresses all three surface markers, or three separate precursor cell populations each of which expresses a single marker. Specific B cell subpopulations were eliminated by treatment with anti-Ig or anti-Ia and complement, or by rosette formation with erythrocytesantibody-complement followed by differential centrifugation, and surviving cells were subsequently tested for inducibility of the three B cell markers. From these results we propose the hypothesis that the differentiation of B lymphocytes proceeds through at least four distinct stages characterized by the following phenotypes: IgIa-CRIg+Ia-CR -_ Ig+Ia+CR--_ Ig+Ia+CR+. For many years the study of cell differentiation has been primarily restricted to examination of terminally differentiating cells, i.e., cells that can be easily recognized by their specialized cell products. It has been postulated, however, that each cell lineage is comprised of several precursor cell populations related to each other in precise temporal sequence, and further that each population consists of differentiated cells synthesizing their own "luxury" molecules by which they can be described and assigned to distinct compartments in the cell lineage (1, 2 MATERIALS AND METHODS Mice. Three-to four-week-old (B6 X A)F1 mice from the Sloan-Kettering colony were used.
version of prothymocytes (ThyI-) to thymocytes Thy-1+) From these results we propose the hypothesis that the differentiation of B lymphocytes proceeds through at least four distinct stages characterized by the following phenotypes: IgIa-CRIg+Ia-CR -_ Ig+Ia+CR--_ Ig+Ia+CR+. For many years the study of cell differentiation has been primarily restricted to examination of terminally differentiating cells, i.e., cells that can be easily recognized by their specialized cell products. It has been postulated, however, that each cell lineage is comprised of several precursor cell populations related to each other in precise temporal sequence, and further that each population consists of differentiated cells synthesizing their own "luxury" molecules by which they can be described and assigned to distinct compartments in the cell lineage (1, 2) . In reality, distinguishing morphological criteria, such as those accompanying, for example, erythroid maturation or gametogenesis, are the exception for most precursor populations. Our inability to distinguish and isolate precursor populations has made it virtually impossible to analyze fully the developmental history of any cell lineage.
With the discovery that different cell types exhibit unique cell surface antigens (3) it became possible to look for molecular markers on precursor populations, in particular those belonging to the lymphoid series in mice. The lymphocytes (<1% rosettes) were pelleted at 100 X g and resuspended in medium to 20 X 106 lymphocytes per ml. To lyse erythrocytes, 4 volumes of distilled water were added, followed after 20 sec by 1 volume of 4.25% NaCl. The cells were then spun down, washed once in medium RPMI 1640, and fractionated on the bovine serum albumin gradient. Bovine Serum Albumin Gradient Fractionation; Induction Assays; Antisera; Cytotoxicity Assays; and Rosette Assay for CR+ Cells. These were described in detail (6) .
RESULTS
Three independent B cell surface markers, Ig (9), Ia (10-12), and CR (8) , have been shown to be inducible (13) . The following experiments were designed to determine whether: (i) the three components are induced simultaneously on a homogeneous population of B precursor cells, as is the case with thymusderived (T) cell alloantigens in prothymocyte induction (4), or whether (ii) different populations respond to Escherichia coli lipopolysaccharide (LPS), each expressing a new marker as a result of induction.
Since homogeneous populations of B precursor cells to date have not been sufficiently purified, we have chosen the indirect method of eliminating the subpopulations defined by the three surface markers Ig, Ia, and CR, and testing in the surviving populations which of the markers appear after induction.
Effect of anti-Ig pretreatment
Bone marrow or spleen populations were subjected to mass cytolysis with anti-ii,K antibody, or with anti-y antibody (control). The surviving cells, after gradient separation, were then tested in the induction assay, with LPS as the inducing agent.
Net inductions of the following markers were scored: 1g, Ia, CR, and Thy-i (14) . Thy-i identifies the conversion of prothymocytes to thymocytes, which should not be impaired by selective B cell treatments, and therefore serves as a control to safeguard against nonspecific effects. It is evident that the elimination of Ig+ cells from both populations completely prevents the conversion of Ia-to Ia+ cells, and in spleen populations that of CRto CR+ (Table 1) . Bone (i) Ig-Ia-CR-to Ig+Ia-CR-(since this conversion is insensitive to pretreatment with anti-Ig, anti-Ia, or EAC);
(ii) Ig+Ia-CR-to Ig+Ia+CR-(since Ia-inducible cells are sensitive to anti-Ig, but not CR (depletion)).
(iM) Ig+Ia+CR-to Ig+Ia+CR+ (since both anti-Ig and anti-Ia treatments abolish CR induction). There is preliminary evidence to support a fourth conversion relating to the plasma cell antigen Pc-i (19) :
(iv) Ia+CR+Pc-l toIa+CR+Pc-1+.
On the basis of these observations we propose a model of B cell ontogeny in which B precursor cells must pass sequentially through a minimum of four compartments in order to become mature CR+ lymphocytes (Fig. 1) 17 of gestation (23) , and in the human fetus after the ninth week of gestation (24) . These early B cell precursors ("PB" cells) are thought to differentiate stepwise to antigen-responsive B lymphocytes (25) . Ryser and Vassalli (26) and Kearney and Lawton (27) 
